These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 30144539

  • 1. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M, Moore A, Naughton M, Boland B, Siems WE, Walther T.
    Neurosci Lett; 2018 Nov 01; 686():74-79. PubMed ID: 30144539
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
    Rofo F, Metzendorf NG, Saubi C, Suominen L, Godec A, Sehlin D, Syvänen S, Hultqvist G.
    Alzheimers Res Ther; 2022 Dec 05; 14(1):180. PubMed ID: 36471433
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. N-Terminal Truncated Aβ4-42 Is a Substrate for Neprilysin Degradation in vitro and in vivo.
    Hornung K, Zampar S, Engel N, Klafki H, Liepold T, Bayer TA, Wiltfang J, Jahn O, Wirths O.
    J Alzheimers Dis; 2019 Dec 05; 67(3):849-858. PubMed ID: 30664509
    [Abstract] [Full Text] [Related]

  • 6. β-Amyloid and neprilysin computational studies identify critical residues implicated in binding specificity.
    Pope D, Madura JD, Cascio M.
    J Chem Inf Model; 2014 Apr 28; 54(4):1157-65. PubMed ID: 24650257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    Chen PT, Chen CL, Lin LT, Lo CH, Hu CJ, Chen RP, Wang SS.
    PLoS One; 2016 Apr 28; 11(4):e0153360. PubMed ID: 27096746
    [Abstract] [Full Text] [Related]

  • 12. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ.
    PLoS One; 2007 Jul 25; 2(7):e652. PubMed ID: 17653279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.
    Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC.
    J Biol Chem; 2001 Jun 15; 276(24):21895-901. PubMed ID: 11278416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alzheimer's Aβ1-40 peptide degradation by thermolysin: evidence of inhibition by a C-terminal Aβ product.
    Leite JP, Gales L.
    FEBS Lett; 2019 Jan 15; 593(1):128-137. PubMed ID: 30403288
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
    Kanemitsu H, Tomiyama T, Mori H.
    Neurosci Lett; 2003 Oct 23; 350(2):113-6. PubMed ID: 12972166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.